These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24 related articles for article (PubMed ID: 7111018)
1. [The cost of blood diseases to the Assistance Publique of Paris]. Jolly D; Bertrand D Nouv Rev Fr Hematol (1978); 1982; 24(2):99-102. PubMed ID: 7111019 [No Abstract] [Full Text] [Related]
2. [From the editorial board]. Vorob'ev AI Ter Arkh; 2001; 73(7):5-6. PubMed ID: 11523409 [No Abstract] [Full Text] [Related]
3. Cost analysis of procainamide-associated blood dyscrasias. Kessler KM Am J Cardiol; 1995 Sep; 76(8):639-40. PubMed ID: 7677102 [No Abstract] [Full Text] [Related]
4. [Hematopoietic growth factors in oncology and hematology. Recommendations for more cost-efficient use]. Paul C; Hast R Lakartidningen; 2000 Jun; 97(23):2862-6. PubMed ID: 10885223 [No Abstract] [Full Text] [Related]
5. [Hematology: centuries: centuries of experiences/recent discoveries also cheaper]. Fehr J Schweiz Med Wochenschr; 1997 Dec; 127(51-52):2122-4. PubMed ID: 9487571 [No Abstract] [Full Text] [Related]
6. [Need for thrombocytes among hematologic patients. Medical and economic aspects]. Richter J Lakartidningen; 1993 Apr; 90(14):1390-3. PubMed ID: 8479264 [No Abstract] [Full Text] [Related]
7. Nanotechnology in the diagnosis and management of heart, lung and blood diseases. Buxton DB Expert Rev Mol Diagn; 2007 Mar; 7(2):149-60. PubMed ID: 17331063 [TBL] [Abstract][Full Text] [Related]